益方生物：目前公司主要有2款对外授权产品

Core Viewpoint - Yifang Bio has established licensing agreements for two products, indicating a strategic move to expand its market presence and collaboration with other pharmaceutical companies [2] Group 1: Licensing Agreements - The company has two externally licensed products, including Befotalimab, for which it has reached a licensing cooperation with Betta Pharmaceuticals in the regions of mainland China, Hong Kong, and Taiwan [2] - For the product D-1553 (Gosorese), the company has granted an exclusive license to Zhengda Tianqing for the development, registration, production, and commercialization in mainland China [2]